Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 823-832
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Table 1 Preoperative data: Patient demographics and hernia type, n (%)
| Number of patients | n = 28 |
| Sex | |
| Male | 16 (57.1) |
| Female | 12 (42.9) |
| Age, yr | 58.5 ± 16.3 |
| BMI, kg/m2 | 26.2 ± 4.1 |
| Patient type | |
| Stoma-site reinforcement | 21 (75.0) |
| Incisional | 4 (14.3) |
| Stoma-site/incisional | 3 (10.7) |
| CDC wound class | |
| Class I: Clean | 3 (10.7) |
| Class II: Clean/contaminated | 2 (7.1) |
| Class III: Contaminated | 23 (82.1) |
| Recurrent | 5 (17.9) |
| Prior hernia repairs | 5 (17.9) |
| Prior wound infection | 6 (21.4) |
| Transplant patient | 0 (0) |
| Stoma present | 22 (78.6) |
| Cancer | 17 (60.7) |
| Immunosuppression/steroid use | 19 (67.9) |
| Hypoalbuminemia (albumin < 3.7 g/dL) | 12 (42.9) |
| Diabetes | 10 (35.7) |
| COPD/chronic cough | 8 (28.6) |
| Smoking | 8 (28.6) |
| MRSA | 0 (0) |
Table 2 Perioperative data: Mesh/defect dimensions and operative technique, n (%)
| Value | |
| Surgical approach | |
| Open | 3 (10.7) |
| Laparoscopic | 15 (53.6) |
| Robotic | 10 (35.7) |
| Implant location | |
| Sublay | 23 (82.1) |
| IPOM | 5 (17.9) |
| Matrix | |
| OviTex 1S® | 5 (17.9) |
| OviTex LPR® | 23 (82.1) |
| Duration of surgery | 85.7 min ± 40.9 min |
| Defect dimensions | |
| Length | 7.5 cm ± 3.9 cm |
| Width | 6.9 cm ± 3.4 cm |
| Mesh dimensions (cm × cm) | |
| 9 × 9 | 20 (71.4) |
| 10 × 12 | 2 (7.1) |
| 16 × 20 | 4 (14.3) |
| 20 × 20 | 2 (7.1) |
| Component separation | |
| Left myocutaneous flap | 2 (7.1) |
| Right myocutaneous flap | 18 (64.3) |
| Bilateral | 2 (7.1) |
| Unspecified | 1 (3.6) |
| None | 5 (17.9) |
| Bowel anastomosis | 23 (82.1) |
| Intraoperative blood transfusion | 0 (0) |
| Concomitant procedure(s) | 0 (0) |
| Drains placed | |
| At least one | 24 (85.7) |
| None | 4 (14.3) |
| Drain locations | |
| Abdominal wall | 0 (0) |
| Subcutaneous | 23 (82.1) |
| Retromuscular | 3 (10.7) |
| Skin closure | 3 (10.7) |
| Vacuum-assisted closure device | 0 (0) |
Table 3 Postoperative data: Primary and secondary study endpoints
| Item | 1 month | 1 yr |
| Number of patients | 28 | 28 |
| Primary endpoint | ||
| Hernia recurrence | 0 (0) | 0 (0) |
| Secondary endpoints | ||
| Length of stay | 2.1 d ± 1.2 d | NA |
| Return to work | 8.3 d ± 3.0 d | NA |
| Readmission | 3 (10.7) | 0 (0) |
| Wound | 0 (0) | 0 (0) |
| Mesh infection | 2 (7.1) | 0 (0) |
| Gastrointestinal | 2 (7.1) | 0 (0) |
| Surgical site infection | ||
| Superficial | 0 (0) | NA |
| Deep | 0 (0) | NA |
| Seroma | 0 (0) | 0 (0) |
| Hematoma | 0 (0) | NA |
| Wound dehiscence | 0 (0) | NA |
| Fistula | 2 (7.1) | 0 (0) |
| Mechanical obstruction | 0 (0) | 0 (0) |
| Mesh infection | 2 (7.1) | 0 (0) |
| Mesh removal | 1 (3.6) | 0 (0) |
- Citation: Lake SP, Deeken CR, Agarwal AK. Reinforced tissue matrix to strengthen the abdominal wall following reversal of temporary ostomies or to treat incisional hernias. World J Gastrointest Surg 2024; 16(3): 823-832
- URL: https://www.wjgnet.com/1948-9366/full/v16/i3/823.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.823
